Cargando…

A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study

BACKGROUND: Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasseur, Michèle, Simon, Nicolas, Picher, Chloé, Richeval, Camille, Soichot, Marion, Humbert, Luc, Barthélémy, Christine, Fleury-Souverain, Sandrine, Bonnabry, Pascal, Décaudin, Bertrand, Allorge, Delphine, Odou, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082556/
https://www.ncbi.nlm.nih.gov/pubmed/30089139
http://dx.doi.org/10.1371/journal.pone.0201335
_version_ 1783345822288576512
author Vasseur, Michèle
Simon, Nicolas
Picher, Chloé
Richeval, Camille
Soichot, Marion
Humbert, Luc
Barthélémy, Christine
Fleury-Souverain, Sandrine
Bonnabry, Pascal
Décaudin, Bertrand
Allorge, Delphine
Odou, Pascal
author_facet Vasseur, Michèle
Simon, Nicolas
Picher, Chloé
Richeval, Camille
Soichot, Marion
Humbert, Luc
Barthélémy, Christine
Fleury-Souverain, Sandrine
Bonnabry, Pascal
Décaudin, Bertrand
Allorge, Delphine
Odou, Pascal
author_sort Vasseur, Michèle
collection PubMed
description BACKGROUND: Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cleaning procedure + specific decontamination procedure. METHODS AND FINDINGS: A comparative and prospective study was carried out in a newly opened compounding unit. Compounding was performed with a CSTD (BD-Phaseal, Becton-Dickinson). In the Control isolator (C), the cleaning process was completed daily with a standard biocide solution (Anioxyspray(TM), Anios, France). In the Intervention isolator (I), weekly decontamination with a homemade admixture of sodium dodecyl sulfate 10(−2) M/70% isopropanol (80/20, v/v) was added. Monitoring was performed via a validated LC-MS/MS method. Eight drugs (cyclophosphamide, cytarabine, dacarbazine, fluorouracile, gemcitabine, ifosfamide, irinotecan and methotrexate) were monitored daily over 14 consecutive weeks on three sites inside the isolators: gloves, workbench and window. Results are presented as the odds-ratio (OR) of contamination and as overall decontamination efficiency (Eff(Q), %). The proportion of Eff(Q) ≥ 90% was assessed by a Fisher’s exact test (p<0.05). Overall contamination rates (CR, %) were significantly different from one isolator to the other (CR(C) = 25.3% vs. CR(I) = 10.4%; OR = 0.341; p<0.0001). Overall Eff(Q) values (median; 1(st) and 3(rd) quartiles) were higher in the intervention isolator (I: 78.3% [34.6%;92.6%] vs. C: 59.5% [-5.5%;72.6%]; p = 0.0015) as well as the proportion of days with an Eff(Q) ≥ 90% (I: 42.9% vs. C: 7.1%; p = 0.077) but very variable depending on drugs. CONCLUSION: Adding a decontamination protocol with a tensioactive agent to a CSTD leads to better control of chemical contamination inside isolators. Improving decontamination by increasing decontamination frequency or modifying the protocol will be further studied.
format Online
Article
Text
id pubmed-6082556
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-60825562018-08-28 A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study Vasseur, Michèle Simon, Nicolas Picher, Chloé Richeval, Camille Soichot, Marion Humbert, Luc Barthélémy, Christine Fleury-Souverain, Sandrine Bonnabry, Pascal Décaudin, Bertrand Allorge, Delphine Odou, Pascal PLoS One Research Article BACKGROUND: Despite the use of closed system drug transfer devices (CSTD), residual contamination from antineoplastic drugs is still detected inside isolators. The aim of this study was to compare the decontamination level obtained using a CSTD + standard cleaning procedure with a CSTD + standard cleaning procedure + specific decontamination procedure. METHODS AND FINDINGS: A comparative and prospective study was carried out in a newly opened compounding unit. Compounding was performed with a CSTD (BD-Phaseal, Becton-Dickinson). In the Control isolator (C), the cleaning process was completed daily with a standard biocide solution (Anioxyspray(TM), Anios, France). In the Intervention isolator (I), weekly decontamination with a homemade admixture of sodium dodecyl sulfate 10(−2) M/70% isopropanol (80/20, v/v) was added. Monitoring was performed via a validated LC-MS/MS method. Eight drugs (cyclophosphamide, cytarabine, dacarbazine, fluorouracile, gemcitabine, ifosfamide, irinotecan and methotrexate) were monitored daily over 14 consecutive weeks on three sites inside the isolators: gloves, workbench and window. Results are presented as the odds-ratio (OR) of contamination and as overall decontamination efficiency (Eff(Q), %). The proportion of Eff(Q) ≥ 90% was assessed by a Fisher’s exact test (p<0.05). Overall contamination rates (CR, %) were significantly different from one isolator to the other (CR(C) = 25.3% vs. CR(I) = 10.4%; OR = 0.341; p<0.0001). Overall Eff(Q) values (median; 1(st) and 3(rd) quartiles) were higher in the intervention isolator (I: 78.3% [34.6%;92.6%] vs. C: 59.5% [-5.5%;72.6%]; p = 0.0015) as well as the proportion of days with an Eff(Q) ≥ 90% (I: 42.9% vs. C: 7.1%; p = 0.077) but very variable depending on drugs. CONCLUSION: Adding a decontamination protocol with a tensioactive agent to a CSTD leads to better control of chemical contamination inside isolators. Improving decontamination by increasing decontamination frequency or modifying the protocol will be further studied. Public Library of Science 2018-08-08 /pmc/articles/PMC6082556/ /pubmed/30089139 http://dx.doi.org/10.1371/journal.pone.0201335 Text en © 2018 Vasseur et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Vasseur, Michèle
Simon, Nicolas
Picher, Chloé
Richeval, Camille
Soichot, Marion
Humbert, Luc
Barthélémy, Christine
Fleury-Souverain, Sandrine
Bonnabry, Pascal
Décaudin, Bertrand
Allorge, Delphine
Odou, Pascal
A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study
title A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study
title_full A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study
title_fullStr A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study
title_full_unstemmed A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study
title_short A decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. A prospective, parallel study
title_sort decontamination process adding a tensioactive agent and isopropanol to a closed-system drug transfer device for better control of isolator contamination. a prospective, parallel study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082556/
https://www.ncbi.nlm.nih.gov/pubmed/30089139
http://dx.doi.org/10.1371/journal.pone.0201335
work_keys_str_mv AT vasseurmichele adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT simonnicolas adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT picherchloe adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT richevalcamille adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT soichotmarion adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT humbertluc adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT barthelemychristine adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT fleurysouverainsandrine adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT bonnabrypascal adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT decaudinbertrand adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT allorgedelphine adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT odoupascal adecontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT vasseurmichele decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT simonnicolas decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT picherchloe decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT richevalcamille decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT soichotmarion decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT humbertluc decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT barthelemychristine decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT fleurysouverainsandrine decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT bonnabrypascal decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT decaudinbertrand decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT allorgedelphine decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy
AT odoupascal decontaminationprocessaddingatensioactiveagentandisopropanoltoaclosedsystemdrugtransferdeviceforbettercontrolofisolatorcontaminationaprospectiveparallelstudy